Page last updated: 2024-08-23

vecuronium bromide and Obesity, Morbid

vecuronium bromide has been researched along with Obesity, Morbid in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Herring, WJ; Maganti, L; Mostoller, K; van Zutphen-van Geffen, M; Wrishko, R	1
Blobner, M; DeAngelis, M; Herring, WJ; Horrow, JC; Li, W; Lombard, J; Speek, M	1
Dohgomori, H; Joshita, S; Kikuchi, T; Mochizuki, K; Nitta, K; Okamoto, K; Ozawa, M; Tsukahara, Y	1
Fujinaga, A; Fukushima, Y; Kojima, A; Kuzukawa, A; Nosaka, S; Ohashi, Y; Sai, Y; Seto, T	1

Trials

2 trial(s) available for vecuronium bromide and Obesity, Morbid

Article	Year
Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery. Clinical and translational science, 2021, Volume: 14, Issue:2 Topics: Adult; Body Mass Index; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Humans; Ideal Body Weight; Male; Middle Aged; Models, Biological; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Obesity, Morbid; Rocuronium; Sugammadex; Vecuronium Bromide	2021
Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial. BMC anesthesiology, 2021, 02-27, Volume: 21, Issue:1 Topics: Anesthesia Recovery Period; Body Weight; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ideal Body Weight; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Obesity, Morbid; Rocuronium; Sugammadex; Time Factors; Vecuronium Bromide	2021

Article

Year

Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery.

Clinical and translational science, 2021, Volume: 14, Issue:2

Topics: Adult; Body Mass Index; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Humans; Ideal Body Weight; Male; Middle Aged; Models, Biological; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Obesity, Morbid; Rocuronium; Sugammadex; Vecuronium Bromide

2021

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.

BMC anesthesiology, 2021, 02-27, Volume: 21, Issue:1

Topics: Anesthesia Recovery Period; Body Weight; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ideal Body Weight; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Obesity, Morbid; Rocuronium; Sugammadex; Time Factors; Vecuronium Bromide

2021

Other Studies

2 other study(ies) available for vecuronium bromide and Obesity, Morbid

Article	Year
[Anesthesia for a patient with morbid obesity, systemic edema and airway burn]. Masui. The Japanese journal of anesthesiology, 2010, Volume: 59, Issue:4 Topics: Adult; Anesthesia, Intravenous; Burns; Edema; Fentanyl; Humans; Intubation, Intratracheal; Laryngoscopes; Male; Obesity, Morbid; Propofol; Respiratory System; Skin Transplantation; Vecuronium Bromide; Ventilators, Mechanical	2010
Anesthetic management of an extremely obese patient. Journal of anesthesia, 2007, Volume: 21, Issue:2 Topics: Adenocarcinoma; Adult; Anesthesia; Anesthesia, Epidural; Anesthetics, Local; Endometrial Neoplasms; Female; Humans; Hysterectomy; Intubation, Intratracheal; Monitoring, Intraoperative; Obesity, Morbid; Pelvic Inflammatory Disease; Posture; Vecuronium Bromide	2007